Professor Daniel Hochhauser is a renowned specialist in the treatment of gastrointestinal cancer. He is currently affiliated with a leading hospital where he focuses on developing novel therapeutics to improve patient outcomes.

Professor Hochhauser's medical journey began at Cambridge and the Royal Free Hospital Medical School, where he qualified in medicine. He pursued postgraduate training and was appointed as a Clinical Fellow in Medical Oncology at the Institute of Molecular Medicine, Oxford. During his time there, he completed a DPhil, further honing his expertise. His training continued at the prestigious Memorial Sloan Kettering Cancer Center in New York. In 1996, he was appointed as a consultant, marking the beginning of his distinguished career.

Professor Hochhauser's areas of expertise include the treatment of both upper and lower gastrointestinal cancers. He is particularly skilled in administering chemotherapy for these conditions. One of his notable roles involves conducting home chemotherapy, providing patients with the convenience and comfort of receiving treatment in their own homes.

In addition to his clinical work, Professor Hochhauser is deeply involved in research, focusing on the development of new therapeutic approaches for gastrointestinal cancers. His dedication to advancing medical knowledge and improving patient care is evident in his ongoing research efforts.

Since his appointment as a consultant, Professor Hochhauser has been committed to treating a wide range of gastrointestinal cancers, including both upper and lower gastrointestinal malignancies. His extensive training and experience make him a leading figure in the field of medical oncology.

Professor Hochhauser's interests extend beyond his clinical and research roles. He is passionate about educating the next generation of medical professionals and often participates in teaching and mentoring activities.

In summary, Professor Daniel Hochhauser is a highly respected medical specialist with a wealth of experience in treating gastrointestinal cancers. His commitment to research, patient care, and education has made him a prominent figure in the field of medical oncology.